Evolutionary etiology of high-grade astrocytomas

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 44, 2013, Pages 17933-17938

  Song, Yurong ^a   Zhang, Qian ^b   Kutlu, Burak ^c   Difilippantonio, Simone ^d   Bash, Ryan ^e   Gilbert, Debra ^a   Yin, Chaoying ^f   O'Sullivan, T Norene ^a   Yang, Chunyu ^f   Kozlov, Serguei ^d   Bullitt, Elizabeth ^g   McCarthy, Ken D ^g   Kafri, Tal ^f   Louisj, David N ^g   Miller, C Ryan ^e   Hood, Leroy ^c   Dyke, Terry Van ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^d SAIC FREDERICK INC   (United States)

^e Gene Therapy Center   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOCITRATE DEHYDROGENASE 1; K RAS PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADVANCED CANCER; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; ENZYME INACTIVATION; GENE DELETION; GENE MUTATION; GENETIC ENGINEERING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INDUCTION; TUMOR SUPPRESSOR GENE;

CANCER INITIATION; CANCER PROGRESSION; MOUSE MODEL PRECLINICAL;

ANIMALS; ASTROCYTOMA; BASE SEQUENCE; BIOLOGICAL EVOLUTION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENETIC ENGINEERING; GLIOBLASTOMA; MICE; MICE, TRANSGENIC; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTO-ONCOGENE PROTEINS P21(RAS); PTEN PHOSPHOHYDROLASE; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84887073728     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1317026110     Document Type: Article

References (41)

1. Louis DN, Ohgaki H, Weistler OD, Cavenee WK, eds (2007) WHO Classification of Tumours of the Central Nervous System (IARC Press, Lyon).
2. Brennan C (2011) Genomic profiles of glioma. Curr Neurol Neurosci Rep 11(3):291-297.
3. Vitucci M, Hayes DN, Miller CR (2011) Gene expression profiling of gliomas: Merging genomic and histopathological classification for personalised therapy. Br J Cancer 104(4):545-553.
4. Phillips HS, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3):157-173.
5. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216):1061-1068.
6. Parsons DW, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807-1812.
7. de Vries NA, Beijnen JH, van Tellingen O (2009) High-grade glioma mouse models and their applicability for preclinical testing. Cancer Treat Rev 35(8):714-723.
8. Furnari FB, et al. (2007) Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 21(21):2683-2710.
9. Hambardzumyan D, Parada LF, Holland EC, Charest A (2011) Genetic modeling of gliomas in mice: New tools to tackle old problems. Glia 59(8):1155-1168.
10. Casper KB, Jones K, McCarthy KD (2007) Characterization of astrocyte-specific conditional knockouts. Genesis 45(5):292-299.
11. Stubdal H, et al. (1997) Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol Cell Biol 17(9):4979-4990.
12. Xiao A, Wu H, Pandolfi PP, Louis DN, Van Dyke T (2002) Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1(2):157-168.
13. Guha A, Feldkamp MM, Lau N, Boss G, Pawson A (1997) Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15(23):2755-2765.
14. Tuveson DA, et al. (2004) Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5(4):375-387.
15. Xiao A, et al. (2005) Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation. Cancer Res 65(12):5172-5180.
16. Danielyan L, et al. (2007) Colocalization of glial fibrillary acidic protein, metallothionein, and MHC II in human, rat, NOD/SCID, and nude mouse skin keratinocytes and fibroblasts. J Invest Dermatol 127(3):555-563.
17. Mentlein R, Kendall MD (2000) The brain and thymus have much in common: A functional analysis of their microenvironments. Immunol Today 21(3):133-140.
18. Inda MM, et al. (2010) Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev 24(16):1731-1745.
19. Petitjean A, et al. (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Hum Mutat 28(6):622-629.
20. Parikh AH, Smith JK, Ewend MG, Bullitt E (2004) Correlation of MR perfusion imaging and vessel tortuosity parameters in assessment of intracranial neoplasms. Technol Cancer Res Treat 3(6):585-590.
21. Verhaak RG, et al.; Cancer Genome Atlas Research Network (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98-110.
22. Niola F, et al. (2013) Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. J Clin Invest 123(1):405-417.
23. Nobusawa S, Watanabe T, Kleihues P, Ohgaki H (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15(19): 6002-6007.
24. Yan H, et al. (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8): 765-773.
25. Chow LM, et al. (2011) Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell 19(3):305-316.
26. Rasheed BK, et al. (1997) PTEN gene mutations are seen in high-grade but not in lowgrade gliomas. Cancer Res 57(19):4187-4190.
27. Marumoto T, et al. (2009) Development of a novel mouse glioma model using lentiviral vectors. Nat Med 15(1):110-116.
28. Holland EC, et al. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25(1):55-57.
29. Sharpless NE, DePinho RA (1999) The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 9(1):22-30.
30. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A (2001) Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413(6851):83-86.
31. Ortega S, Malumbres M, Barbacid M (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602(1):73-87.
32. Robanus-Maandag E, et al. (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12(11):1599-1609.
33. Dannenberg JH, van Rossum A, Schuijff L, te Riele H (2000) Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 14(23):3051-3064.
34. Sage J, et al. (2000) Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 14(23):3037-3050.
35. Zheng H, et al. (2008) p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455(7216):1129-1133.
36. Jacques TS, et al. (2010) Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. EMBO J 29(1):222-235.
37. Kim HS, et al. (2012) Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc. Cancer Res 72(22):6065-6075.
38. Carro MS, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463(7279):318-325.
39. Jackson EL, et al. (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15(24):3243-3248.
40. Suzuki A, et al. (2001) T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14(5):523-534.
41. Shannon PT, Reiss DJ, Bonneau R, Baliga NS (2006) The Gaggle: An open-source software system for integrating bioinformatics software and data sources. BMC Bioinformatics 7:176.